-+ 0.00%
-+ 0.00%
-+ 0.00%

Venus Medtech flags availability of press release on Venus-PowerX TAVR trial update

PUBT·07/23/2026 06:04:26
Listen to the news
Venus Medtech flags availability of press release on Venus-PowerX TAVR trial update
  • Venus Medtech posted a press release saying patient enrollment is complete in its China pivotal PREVAILS trial for the Venus-PowerX transcatheter aortic valve replacement system.
  • The company said the data will support parallel regulatory submissions to China’s NMPA and for a CE mark in Europe.
  • Venus-PowerX is positioned as a next-generation, self-expanding TAVR device designed for full deployment with full retrieval.
  • The release is available at https://www.prnewswire.com/news-releases/venus-medtech-annonce-la-fin-du-recrutement-des-patients-dans-le-cadre-de-lessai-clinique-decisif-mene-en-chine-sur-le-venus-powerx-le-premier-systeme-tavr-au-monde-a-valve-seche-auto-expansible-et-entierement-recuperable-302832285.html.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: FR09981) on July 23, 2026, and is solely responsible for the information contained therein.